ADCT

ADC Therapeutics SA

ADCT
NYSESmall CapHealthcare

13F Pro Quality Score

21.8/100

Rank #2,759 of 2,961 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

50.9/100

Profitability

6.9/100

Balance Sheet

7.1/100

Earnings Quality

8.9/100

Free Cash Flow

5.9/100

Institutional Flow

13.2/100

Revenue Scale

12.8/100

Dilution Risk

18.1/100

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

Q2 2026
EDGAR

$19.25M

Net Income

Q2 2026
EDGAR

$-16.57M

EPS (Diluted)

Q2 2026
EDGAR

$-0.11

Free Cash Flow

Q2 2026
EDGAR

$-11.81M

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…